Alerts will be sent to your verified email
Verify Email
BPLPHARMA
|
Bharat Parenterals
|
Wanbury
|
Anuh Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.31 % | n/a | 0.0 |
|
Financials
|
|||
|
5 yr Average ROE
|
12.73 % | -30.56 % | 15.87 % |
|
5yr average Equity Multiplier
|
1.76 | -3.1 | 1.62 |
|
5yr Average Asset Turnover Ratio
|
0.86 | 1.51 | 1.35 |
|
5yr Avg Net Profit Margin
|
8.73 % | 7.58 % | 7.23 % |
|
Price to Book
|
2.61 | 14.71 | 2.55 |
|
P/E
|
0.0 | 20.29 | 18.01 |
|
5yr Avg Cash Conversion Cycle
|
122.06 Days | -119.82 Days | 42.81 Days |
|
Inventory Days
|
46.56 Days | 20.62 Days | 50.87 Days |
|
Days Receivable
|
179.99 Days | 49.78 Days | 111.12 Days |
|
Days Payable
|
95.97 Days | 205.91 Days | 117.6 Days |
|
5yr Average Interest Coverage Ratio
|
22.68 | 2.36 | 48.66 |
|
5yr Avg ROCE
|
16.02 % | -51.74 % | 21.17 % |
|
5yr Avg Operating Profit Margin
|
11.16 % | 4.22 % | 10.21 % |
|
5 yr average Debt to Equity
|
0.26 | -0.61 | 0.02 |
|
5yr CAGR Net Profit
|
-9.67 % | -2.79 % | 10.73 % |
|
5yr Average Return on Assets
|
8.0 % | 11.1 % | 9.84 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.19 % | 39.63 % | 69.92 % |
|
Share Pledged by Promoters
|
0.0 | 76.74 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-6.65 % | -0.22 % | -0.67 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bharat Parenterals
|
Wanbury
|
Anuh Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|